Inclusion criteria | Exclusion criteria |
---|---|
1. Men and women | 1. Patients with any of the following symptoms: |
2. Age ≥20 years at informed consent acquisition | - Acute sinusitis or otitis media |
3. Patients with CHF who are undergoing guideline-directed medical therapy | - Symptoms predisposing vomiting in the mask |
4. Patients with CHF capable of using the ASV device at home as outpatients after enrollment | - Incapable of swallowing airway secretions |
- Pneumothorax or mediastinal emphysema | |
5. Patients whose NYHA class at baseline* is greater than or equal to II | - Recent cranial injury or surgery |
6. Patients whose LVEF at baseline* is <40% | - Chronic hypoventilation |
 | 2. Patients at risk of developing any of the following symptoms due to the use of the ASV device |
 | - Hypotension or a significant reduction in intravascular volume |
 | - Intense nasal bleeding leading to the risk of pulmonary aspiration |
 | 3. Patients incapable of giving voluntary consent |
 | 4. Patients with a history of undergoing the treatment of CHF by ASV at home |
 | 5. Patients who are enrolled in another clinical study or trial |
 | 6. Patients diagnosed with or suspected of dementia |
 | 7. Patients whom the attending physician has considered ineligible for this study |